These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

574 related items for PubMed ID: 16050396

  • 1. [Depurative efficiency of intermediate and large molecules with different hemodialysis modalities].
    Maduell F.
    Nefrologia; 2005; 25 Suppl 2():15-8. PubMed ID: 16050396
    [Abstract] [Full Text] [Related]

  • 2. Removal of uraemic retention solutes in standard bicarbonate haemodialysis and long-hour slow-flow bicarbonate haemodialysis.
    Basile C, Libutti P, Di Turo AL, Casino FG, Vernaglione L, Tundo S, Maselli P, De Nicolò EV, Ceci E, Teutonico A, Lomonte C.
    Nephrol Dial Transplant; 2011 Apr; 26(4):1296-303. PubMed ID: 20813765
    [Abstract] [Full Text] [Related]

  • 3. Uremic toxins: a new focus on an old subject.
    Yavuz A, Tetta C, Ersoy FF, D'intini V, Ratanarat R, De Cal M, Bonello M, Bordoni V, Salvatori G, Andrikos E, Yakupoglu G, Levin NW, Ronco C.
    Semin Dial; 2005 Apr; 18(3):203-11. PubMed ID: 15934967
    [Abstract] [Full Text] [Related]

  • 4. Online hemodiafiltration.
    Van Laecke S, De Wilde K, Vanholder R.
    Artif Organs; 2006 Aug; 30(8):579-85. PubMed ID: 16911311
    [Abstract] [Full Text] [Related]

  • 5. Convective therapies for removal of middle molecular weight uremic toxins in end-stage renal disease: a review of the evidence.
    Thomas G, Jaber BL.
    Semin Dial; 2009 Aug; 22(6):610-4. PubMed ID: 20017830
    [Abstract] [Full Text] [Related]

  • 6. [On-line haemodiafiltration with sorbent-regenerated ultrafiltrate as replacement fluid: Beta2-microglobulin removal versus filtration fraction].
    Emiliani G, Briganti M, Montanari A, Isola E, Fusaroli M.
    G Ital Nefrol; 2004 Aug; 21 Suppl 30():S80-4. PubMed ID: 15747312
    [Abstract] [Full Text] [Related]

  • 7. Resolving controversies regarding hemodiafiltration versus hemodialysis: the Dutch Convective Transport Study.
    Penne EL, Blankestijn PJ, Bots ML, van den Dorpel MA, Grooteman MP, Nubé MJ, ter Wee PM, CONTRAST Group.
    Semin Dial; 2005 Aug; 18(1):47-51. PubMed ID: 15663765
    [Abstract] [Full Text] [Related]

  • 8. Role of dialysis technology in the removal of uremic toxins.
    Davenport A.
    Hemodial Int; 2011 Oct; 15 Suppl 1():S49-53. PubMed ID: 22093601
    [Abstract] [Full Text] [Related]

  • 9. [Clinical and metabolic consequences of uremic toxicity].
    Rutkowski P.
    Przegl Lek; 2006 Oct; 63(4):209-17. PubMed ID: 17080744
    [Abstract] [Full Text] [Related]

  • 10. [Cystatin C, beta2-microglobulin and C-reactive protein in hemodiafiltration and on-line endogenous liquid reinfusion and in low flux polysulphone bicarbonate conventional hemodialysis].
    Cristofano C, Vernaglione L, Perniola MA, Lo Barco C, Muscogiuri P, Chimienti S.
    G Ital Nefrol; 2004 Oct; 21 Suppl 30():S197-200. PubMed ID: 15750984
    [Abstract] [Full Text] [Related]

  • 11. Pilot study to assess increased dialysis efficiency in patients with limited blood flow rates due to vascular access problems.
    Mandolfo S, Borlandelli S, Imbasciati E, Badalamenti S, Graziani G, Sereni L, Varesani M, Wratten ML, Corsi A, Elli A.
    Hemodial Int; 2008 Jan; 12(1):55-61. PubMed ID: 18271842
    [Abstract] [Full Text] [Related]

  • 12. [Ways of intensification of hemodialysis therapy].
    Filiptsev PIa, Kirkhman VV, Timokhov VS.
    Ter Arkh; 1988 Jan; 60(6):44-7. PubMed ID: 3206368
    [Abstract] [Full Text] [Related]

  • 13. [Comparison between two different on-line dialytic techniques: Standard HFR vs post-dilutional HFR].
    Meloni C, Ghezzi PM, Petroni S, Tatangelo P, Massa P, Tozzo C, Recino G, Rossi V, Cecilia A, Casciani CU.
    G Ital Nefrol; 2004 Jan; 21 Suppl 30():S172-6. PubMed ID: 15750979
    [Abstract] [Full Text] [Related]

  • 14. [The hemodiafiltration with endogenous reinfusion reduces the erythroid progenitor inhibition by uremic serum].
    Aucella F, Scalzulli RP, Vigilante M, Stallone C.
    G Ital Nefrol; 2004 Jan; 21 Suppl 30():S128-32. PubMed ID: 15750970
    [Abstract] [Full Text] [Related]

  • 15. Middle molecule accumulation in uremia: an "extra uremic factor".
    Oulès R, Emond C, Claret G, Branger B, Mion H, Mion C.
    Artif Organs; 1981 Jan; 4 Suppl():177-83. PubMed ID: 7295089
    [Abstract] [Full Text] [Related]

  • 16. Extracorporeal strategies for the removal of middle molecules.
    Winchester JF, Audia PF.
    Semin Dial; 2006 Jan; 19(2):110-4. PubMed ID: 16551287
    [Abstract] [Full Text] [Related]

  • 17. [Aspects of the on-line hemodiafiltration with regeneration and reinfusion of the ultrafiltrate (HFR): multicenter study].
    De Simone W, De Simone M, De Simone A, Iannaccone S, Manganelli R, Zito B, Guastaferro P, Apperti V, Paglionico C, Salvati G, Veniero P, Ferro F, Tedesco V.
    G Ital Nefrol; 2004 Jan; 21 Suppl 30():S161-7. PubMed ID: 15750977
    [Abstract] [Full Text] [Related]

  • 18. [Middle molecules removal. Beyond beta2-microglobulin].
    Maduell F, Sánchez-Canel JJ, Blasco JA, Navarro V, Ríus A, Torregrosa E, Pin MT, Cruz C, Ferrero JA.
    Nefrologia; 2006 Jan; 26(4):469-75. PubMed ID: 17058859
    [Abstract] [Full Text] [Related]

  • 19. Release of uremic retention solutes from protein binding by hypertonic predilution hemodiafiltration.
    Böhringer F, Jankowski V, Gajjala PR, Zidek W, Jankowski J.
    ASAIO J; 2015 Jan; 61(1):55-60. PubMed ID: 25419832
    [Abstract] [Full Text] [Related]

  • 20. Biochemical and clinical evidence for uremic toxicity.
    Bouré T, Vanholder R.
    Artif Organs; 2004 Mar; 28(3):248-53. PubMed ID: 15046622
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.